Outcomes of Minimally Interrupted versus Uninterrupted Direct Oral Anticoagulants Use Prior to Implantation of Cardiac Implantable Electronic Devices
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70289 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Qiying Dai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Health System, La Crosse, Wisconsin, USA. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Thromboembolism, Pacemaker, Artificial, Prosthesis Implantation. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Background
Optimal management of direct oral anticoagulants (DOAC) prior to implantation of cardiac implantable electronic devices (CIED) remains controversial.
Objective
To determine whether a strategy of minimal interruption of DOAC before cardiac CIED implantation is associated with improved clinical outcomes compared to uninterrupted DOAC use.
Methods
The electronic clinical records of 310 patients who were on DOAC and underwent CIED implantation were evaluated. The patients were separated into 2 groups: patients in Group 1 had minimal DOAC interruption (DOAC held < 24 h before procedure), while patients in Group 2 continued DOAC before procedure. Resumption of DOAC in both groups was on the same day of the procedure or the next morning at the operator's discretion. Clinically significant pocket hematoma and thromboembolic events were compared.
Results
Among the 310 patients, 71 (22.9%) of them had DOAC held < 24 h before procedure, while DOAC was continued without interruption in 239 (77.1%) in the periprocedural period. Clinically significant pocket hematomas were found in 1 patient (1.4%) in the DOAC interrupted group and 24 (10.0%) in the DOAC continuous group ( p = 0.046). Low thromboembolic events were observed in both groups: 0 in the minimally interrupted group and 1 (0.4%) in the un‐interrupted group ( p > 0.05).
Conclusion
The bleeding risk in our cohort of patients who underwent CIED implantation with the uninterrupted DOAC approach is higher than previously reported in the literature. A minimally interrupted approach appears to mitigate this risk without significantly increasing the risk of thromboembolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Health System, La Crosse, Wisconsin, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiology, Marshfield Clinic Health System, Marshfield, Wisconsin, USA.
Zitieren
APA
Dai, Q., Khan, H. R. A., Tian, Z., Wang, W., & Liu, X. (2026). Outcomes of Minimally Interrupted versus Uninterrupted Direct Oral Anticoagulants Use Prior to Implantation of Cardiac Implantable Electronic Devices. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70289
Vancouver
Dai Q, Khan HRA, Tian Z, Wang W, Liu X. Outcomes of Minimally Interrupted versus Uninterrupted Direct Oral Anticoagulants Use Prior to Implantation of Cardiac Implantable Electronic Devices. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70289
BibTeX
@article{Dai2026,
author = {Dai, Qiying and Khan, Hina Rmsha Alfia and Tian, Zou and Wang, Weijia and Liu, Xiaoke},
title = {Outcomes of Minimally Interrupted versus Uninterrupted Direct Oral Anticoagulants Use Prior to Implantation of Cardiac Implantable Electronic Devices},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70289}
}
EUVIMED